4.6 Article

Sezary syndrome originates from heavily mutated hematopoietic progenitors

Related references

Note: Only part of the references are listed.
Article Immunology

TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures

Ricardo A. Chaurio et al.

Summary: Regulation of PD-1 expression on Tfh cells affects Tfh cell differentiation. Inhibiting SATB1 expression promotes Tfh cell differentiation and enhances immune responses. Transfer of Tfh cells can induce TLS formation and inhibit tumor growth.

IMMUNITY (2022)

Article Hematology

Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors

Aishwarya Iyer et al.

Summary: Mature T-cell lymphomas (TCLs) are rare hematologic cancers with poor prognosis. In this study, the researchers attempted to identify the cell of origin in TCLs by tracing the clonal history of the T cells using T-cell receptor (TCR) recombinations. They found that TCLs are initiated at the level of lymphoid precursor cells and have clonotypically diverse initiating cells. This finding provides important insights into the pathogenesis of TCLs.

BLOOD ADVANCES (2022)

Article Oncology

Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Carmen M. Anadon et al.

Summary: This study reveals that tissue-resident memory (TRM) cells are the main type of T cells infiltrating ovarian cancer. These TRM cells, specifically the progenitor TRMstem cells, play a crucial role in predicting the outcome of ovarian cancer. The findings suggest that ovarian cancer is immunogenic, but only a small portion of tumor-infiltrating T cells have tumor antigen reactivity.

CANCER CELL (2022)

Article Oncology

Clinical characteristics and prognostic factors of 70 patients with Sezary syndrome: a single-institutional experience at Moffitt cancer center

Yumeng Zhang et al.

Summary: Sezary syndrome is a rare and aggressive leukemic variant of cutaneous T-cell lymphoma with a median overall survival rate of 2-4 years. Targeted therapies have shown to be effective in treating refractory patients, and younger female patients have a better prognosis.

LEUKEMIA & LYMPHOMA (2022)

Article Oncology

Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma

Xiaofei Song et al.

Summary: This study comprehensively investigated the tumor ecosystem of transformed CTCL using multiomics approaches. The findings revealed high tumor mutation burden, recurrently mutated pathways, and immune escape related changes in tCTCL. In addition, pharmacologic perturbation targeting OXPHOS and MYC showed promising antitumor activities, and intercellular communications between malignant T cells and macrophages/B cells were identified.

CANCER DISCOVERY (2022)

Article Dermatology

High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma

Bufang Xu et al.

Summary: Cutaneous T cell lymphoma is a chronic disease that can exhibit aggressive behavior in advanced stages, leading to poor prognosis. The transcription factor IKZF2 is found to be overexpressed in malignant T cells, particularly in advanced-stage lesions, promoting disease progression by inhibiting cell apoptosis and potentially contributing to tumor immune evasion.

ACTA DERMATO-VENEREOLOGICA (2021)

Article Biochemistry & Molecular Biology

An NK-like CAR T cell transition in CAR T cell dysfunction

Charly R. Good et al.

Summary: CAR T cell therapy has achieved success in hematological malignancies but faces challenges in solid tumors due to CAR T cell exhaustion. Dysfunction of CAR T cells in solid tumors is associated with CD8+ T-to-NK-like T cell transition, and genetic downregulation of ID3 and SOX4 expression can improve the efficacy of CAR T cell therapy.
Article Medicine, Research & Experimental

Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice

Carly M. Harro et al.

Summary: In this study, it was discovered that the SATB1 gene is epigenetically regulated by methyltransferases in human Sezary syndrome, and inhibition of these methyltransferases can restore SATB1 expression, thereby suppressing lymphoma cell growth. This provides a new therapeutic approach for patients with mycosis fungoides/Sezary syndrome, addressing an unmet need in incurable diseases.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

Pan-cancer single cell landscape of tumor-infiltrating T cells

Liangtao Zheng et al.

Summary: This study constructed a pan-cancer atlas of T cells across 21 cancer types, revealing different composition patterns and state-transition paths of T cells. The correlation between certain T cell populations and patient characteristics sheds light on possible determinants of the tumor microenvironment, providing new insights into T cell immunity and precision immunotherapy.

SCIENCE (2021)

Review Oncology

Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia

Anthony Hunter et al.

Summary: The genomic landscape of chronic myelomonocytic leukemia is complex and characterized by a diverse array of somatic mutations, which play an increasingly important role in diagnosis, risk stratification, and therapeutic decision-making. Somatic mutations have been shown to impact patient prognosis independently of other factors.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2021)

Article Hematology

Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures

Alberto Herrera et al.

Summary: CTCL is a group of mature T-cell tumors that accumulate in the skin, with potential spread to the blood and lymph nodes. Analysis reveals transcriptional and genetic evolution in malignant T-cell populations, with environmental signals and genetic aberrations influencing their profiles. The skin microenvironment promotes a transcriptional response supporting rapid malignant expansion, shedding light on the need for personalized therapy to target all subclones.

BLOOD (2021)

Article Hematology

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

Joonhee Park et al.

Summary: The study identified 86 putative driver genes in CTCL, including 19 genes not previously implicated in the disease and two mutations never described in any cancer. Functional assays revealed that these mutations enhance T-cell receptor-dependent proliferation, highlighting their importance in lymphomagenesis. Investigations into genetic causes of CTCL heterogeneity found that while there are broad similarities across disease stages, there are significantly more structural variants in leukemic disease, leading to highly recurrent deletions of putative tumor suppressors.

BLOOD (2021)

Article Multidisciplinary Sciences

Interpretation of T cell states from single-cell transcriptomics data using reference atlases

Massimo Andreatta et al.

Summary: The authors successfully established reference T cell atlases for cancer and viral infection by integrating multiple studies and developing ProjecTILs algorithm. It accurately predicts cell perturbations effects and identifies highly conserved T cell subtypes, providing a stable basis for describing T cell heterogeneity consistently across different diseases and species.

NATURE COMMUNICATIONS (2021)

Article Oncology

New Insights Into the Complex Mutational Landscape of Sezary Syndrome

Abu-Sayeef Mirza et al.

FRONTIERS IN ONCOLOGY (2020)

Article Multidisciplinary Sciences

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

Omar Khan et al.

NATURE (2019)

Article Medical Laboratory Technology

Naive/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification

Pedro Horna et al.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)

Article Dermatology

SATB1 in Malignant T Cells

Simon Fredholm et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Article Cell Biology

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sezary syndrome

Elisabetta Caprini et al.

CELL DEATH & DISEASE (2018)

Review Hematology

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?

Bieke Soen et al.

HEMASPHERE (2018)

Article Multidisciplinary Sciences

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Se Jin Im et al.

NATURE (2016)

Article Multidisciplinary Sciences

Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress

Tim I. M. Malcolm et al.

NATURE COMMUNICATIONS (2016)

Article Medicine, General & Internal

TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides

Gitte Wooler et al.

FRONTIERS IN MEDICINE (2016)

Article Genetics & Heredity

Genomic landscape of cutaneous T cell lymphoma

Jaehyuk Choi et al.

NATURE GENETICS (2015)

Article Genetics & Heredity

The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome

Ana Carolina da Silva Almeida et al.

NATURE GENETICS (2015)

Article Oncology

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphael Itzykson et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Letter Dermatology

Mycosis Fungoides in the Setting of T-cell Large Granular Lymphocyte Proliferative Disorder

Andrea Saggini et al.

ACTA DERMATO-VENEREOLOGICA (2012)

Article Biochemistry & Molecular Biology

A human memory T cell subset with stem cell-like properties

Luca Gattinoni et al.

NATURE MEDICINE (2011)

Article Immunology

Tracing thymic output in older individuals

W. A. Mitchell et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Article Oncology

Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma

K Yamanaka et al.

CLINICAL CANCER RESEARCH (2005)

Article Hematology

Bone marrow precursor of extranodal T-cell lymphoma

R Gniadecki et al.

BLOOD (2003)

Article Medicine, General & Internal

Brief report: Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation

KD Berg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)